恩帕吉菲
医学
心力衰竭
射血分数
糖尿病
二羟基化合物
内科学
广谱
射血分数保留的心力衰竭
心脏病学
2型糖尿病
内分泌学
化学
有机化学
双酚A
环氧树脂
组合化学
作者
Milton Packer,Stefan D. Anker,Javed Butler,Gerasimos Filippatos,Stuart Pocock,Peter E. Carson,James L. Januzzi,Subodh Verma,Hiroyuki Tsutsui,Martina Brueckmann,Waheed Jamal,Karen Kimura,Janet Schnee,Cordula Zeller,Daniel Cotton,Edimar Alcides Bocchi,Michael Böhm,Dong‐Ju Choi,Vijay Chopra,Eduardo Chuquiure‐Valenzuela
标识
DOI:10.1056/nejmoa2022190
摘要
Among patients receiving recommended therapy for heart failure, those in the empagliflozin group had a lower risk of cardiovascular death or hospitalization for heart failure than those in the placebo group, regardless of the presence or absence of diabetes. (Funded by Boehringer Ingelheim and Eli Lilly; EMPEROR-Reduced ClinicalTrials.gov number, NCT03057977.).
科研通智能强力驱动
Strongly Powered by AbleSci AI